. Although the basic mechanisms of pulmonary fibrosis remain unknown, increased expression of TGF-␤ 1 is believed to be a critical mediator of a complex, multi-phase process during initiation and progression of fibrosis and remodeling (42, 48) . For example, elevated levels of TGF-␤ 1 mRNA and TGF-␤ protein were detected in alveolar macrophages, myofibroblasts, and fibroblasts in lung biopsies obtained from idiopathic pulmonary fibrosis (IPF) patients and rodent bleomycin (BLM)-induced pulmonary fibrosis models (5, 25, 26, 35, 36, 44) . In addition, pharmacological and genetic intervention targeting TGF-␤ 1 action on fibroblasts, such as administration of anti-TGF-␤ 1 neutralizing antibody, dominant negative TGF-␤ receptor, or interferon (IFN)-␤, which is expected to be a potent inhibitor of fibrotic disorders, ameliorates BLM-induced pulmonary fibrosis (19) . Furthermore, enforced expression of bioactive human TGF-␤ 1 in the lungs of transgenic mice was shown to recapitulate several key pathophysiologies observed in fibrotic lung disorders (25) .
TGF-␤ 1 promotes multiple features associated with fibrosis, such as fibroblast migration, proliferation, myofibroblast differentiation, and excessive production of extracellular matrix (ECM) components (44) . TGF-␤ 1 acts through binding to a transmembrane receptor, which in turn phosphorylates Smad2 and Smad3 (29, 30, 47) . These activated Smads then translocate to the nucleus with binding partner Smad4, and this complex regulates a wide range of target genes that are relevant to tissue fibrosis through cis-regulatory elements that serve as binding sequence of Smad proteins. Positive and negative changes in the expression of several hundred TGF-␤ 1 -responsive genes at least partly depend on the associated partners of Smads (43) .
cDNA microarray-based gene expression profiling data obtained from a BLM-induced pulmonary fibrosis model and from IPF patients revealed that expression of the genes involved in oxygen transport are the most significantly dysregulated, suggesting an important role for hypoxia-inducible factor-1 (HIF-1) signaling in pulmonary fibrosis (49) . HIF-1 is a basic helix-loop-helix transcription factor composed of HIF-1␣ and HIF-1␤ (40, 41) . While under normoxia, HIF-1␣ becomes hydroxylated at proline residues and degraded in the proteasome; under hypoxia, HIF-1␣ becomes stabilized, translocates to the nucleus, and induces transcription of target genes. Recent studies have demonstrated that HIF-1␣ expression is increased by non-hypoxic stimuli such as TGF-␤ 1 and PDGF, inflammatory cytokines (tumor necrosis factor (TNF)-␣, interleukin (IL)-1␤, and angiotensin II in vascular smooth muscle cells (SMC), and by a variety of growth factors including epidermal growth factor, insulin, and insulin-like growth factor in hepatocytes (9, 12, 15, 23, 24, 34, 38, 45). However, it remains unclear whether genes that are relevant to lung function under physiological and pathological conditions are regulated by HIF-1 under normoxia.
Among the numerous genes whose expression is regulated by TGF-␤ and HIF-1␣, plasminogen activator inhibitor-1 (PAI-1), the primary inhibitor of plasminogen activators (u-PA, t-PA), has been proven to play a key role in the development of pulmonary fibrosis (8, 14) . BLM-induced fibrosis is more severe in transgenic mice overexpressing the PAI-1 gene than wild-type mice, whereas PAI-1 knockout mice were protected from fibrosis. Several hypotheses have been proposed to explain how PAI-1 deficiency prevents lung fibrosis, varying from an enhancement of plasmin-mediated proteolysis of fibrin to enhanced proteolysis of growth factors and matrix metalloproteinases (MMP) that degrade matrix glycoproteins (27) . In addition, PAI-1 was consistently and dramatically upregulated in pulmonary fibrosis (33) .
The objective of the present study was to determine whether HIF-1␣ could be implicated in the induction of PAI-1 expression in alveolar macrophages. We demonstrated that TGF-␤ induces PAI-1 expression through the accumulation of HIF-1␣ via Smad3-dependent inhibition of PHD-2 expression. Furthermore, we demonstrate that TGF-␤ 1 induction of PDGF-A was significantly diminished by HIF-1␣ knockdown, suggesting the important role of HIF-1␣ in alveolar macrophages in pulmonary fibrosis.
MATERIALS AND METHODS
Antibodies. HIF-1␣, PHD-1, PHD-2, and PHD-3 (Novus Biological, Littleton, CO), PAI-1 (Abcam, Cambridge, MA), Mac3 (BD Biosciences, Mississauga, ON), Smad3, phospho-Smad3, p44/42, phospho-p44/42, p38, and phospho-p38 (Cell Signaling Technology, Beverly, MA).
Mice. Animal experiments were performed according to the guidelines of the Committee of Experimental Animal Research of Gunma University. Male 8-wk-old C57BL/6 mice were anesthetized and instilled with BLM (5 mg/kg) intratracheally as an aerosol using a microsprayer (Penn-Century, Philadelphia, PA). Control mice received saline. Mice were killed 1, 3, 7, 14, and 21 days after BLM administration.
Tissue processing. The left lungs were ligated and frozen. Tissue was removed for RT-PCR. The right lungs were inflated by instilling with 10% formalin at a constant pressure of 25-cm formalin (for 10 min) and fixed for 24 h before paraffin embedding. Serial sections were prepared for histological analysis.
Bronchoalveolar lavage. Bronchoalveolar lavage (BAL) was performed using a 20-G intravenous catheter inserted into the trachea. Lungs were lavaged with 0.75 ml of PBS four times and then centrifuged at 3,000 revolutions/min for 3 min. Supernatant without cell pellets were used for the PAI-1 ELISA.
Immunohistochemistry. Lung sections were deparaffinized in xylene and rehydrated through graded ethanol washes. HIF-1␣ and mac3 immunostaining was performed using the Vectastatin Elite ABC Kit (Vector Laboratories, Burlingame, CA). PAI-1 staining was performed using the CSA Kit (Dako, Glostrup, Denmark). Negative controls were stained by substituting the primary antibody for a nonspecific antibody.
RNA analysis. Total RNA was extracted using RNAiso Plus (Takara Bio, Kyoto, Japan) according to the manufacturer's protocol. Single-stranded cDNAs were synthesized from 1 g of total RNA and semiquantitative RT-PCR was performed with an RT-PCR kit (Takara Bio). Real-time RT-PCR was performed using SYBER green (TOYOBO, Osaka, Japan) according to the manufacturer's protocol. Each experiment was performed using three samples in each condition. The relative quantities of transcripts were determined using ImageJ software for Windows. All primer sequences are shown in Table 1 .
Cell culture and stimulation. MH-S cells (derived from mouse alveolar macrophage) were obtained from ATCC. Primary alveolar macrophages were obtained from BAL fluid that we collected from lungs of C57BL/6 mice using the method described in BAL. These cells were cultured in RPMI1640 medium supplemented with 10% FBS and 1% penicillin-streptomycin (GIBCO, Gaithersburg, MD) at 37°C in a 5% CO 2 atmosphere. Serum-free medium was added for 24 h before 5 ng/ml rhTGF-␤ 1 (Roche Diagnostics, Manneheim, Germany) was added to the medium and cells were incubated at 37°C. Alternatively, cells were pretreated for 1 h with SB431542 (Sigma, St. Louis, MO), PD98509, and SB203580 (Calbiochem, San Diego, CA) before rhTGF-␤ 1 (5 ng/ml) was added. For hypoxic stimulation, cells were incubated in a jar containing Anaero Pack-Anaero (Ͻ1% O 2, 5% CO 2) or Anaero Pack-MicroAero (8% O2, 5% CO2) (Mitsubishi Gas Chemical, Tokyo, Japan).
siRNA transfection. Transfection of siRNA plasmid was performed with Lipofectamine RNAiMAX Reagent (Invitrogen Life Sciences, Carlsbad, CA) according to the manufacturer's protocol. siRNA oligonucleotides were purchased from Hayashi Kasei. The target sequences of HIF-1␣ siRNA, PHD-2 siRNA, and control siRNA are stated in Table 1 . Control siRNA/HIF-1␣ siRNA (20 nM) or 100 nM control siRNA/PHD-2 siRNA were used for the experiment.
Microarray analysis. cDNA microarray analysis of MH-S cells transfected siHIF-1␣, or siGFP was performed using an oligo microarray system (Agilent). Total RNA was isolated from MH-S cells using an RNeasy Mini kit (QIAGEN, Hilden, Germany) 6 h after TGF-␤1 RT-PCR analyses HIF-1␣ 5=-TGCTCATCAGTTGCCACTTC-3= 5=-TGGGCCATTTCTGTGTGTAA-3= PAI-1 5=-TGATGGCTCAGAGCAACAAG-3= 5=-GCCAGGGTTGCACTAAACAT-3= TGF-␤1 5 =-ATACGCCTGAGTGGCTGTCT-3= 5=-TTCTCTGTGGAGCTGAAGCA-3= Procollagen 1 5=-AGGCTTCAGTGGTTTGGATG-3= 5=-GCAATACCAGGAGCACCATT-3= Procollagen 3 5=-AATGGCTCACCAGGACAAAG-3= 5=-ATCCATCTTTGCCATCTTCG-3= 18s 5=-GTTGGTGGAGCGATTTGTCT-3= 5=-GGCCTCACTAAACCATCCAA-3= Real-time PCR analyses HIF-1␣ 5=-GCAGCAGGAATTGGAACATT-3= 5=-GCATGCTAAATCGGAGGGTA-3= PAI-1 5=-TGATGGCTCAGAGCAACAAG-3= 5=-GCCAGGGTTGCACTAAACAT-3= PDGF-A 5=-GAGATACCCCGGGAGTTGAT-3= 5=-ACTTTGGCCACCTTGACACT-3= GAPDH 5=-AACGACCCCTTCATTGAC-3= 5=-TCCACGACATACTCAGCAC-3= siRNA analyses HIF-1␣ 5=-CAGUUACGAUUGUGAAGUUAA-3= 5=-AACUUCACAAUCGUAACUGGU-3= PHD-2 5=-AUGCGUGACAUGUAUAUAUUA-3= 5=-UAAUAUAUACAUGUCACGCAU-3= GFP (control) 5=-GUUCAGCGUGUCCGGCGAGTT-3= 5=-CUCGCCGGACACGCUGAACTT-3=
HIF, hypoxia-inducible factor; PAI, plasminogen activator inhibitor; TGF, transforming growth factor. treatment and subjected to DNase treatment according to the manufacturer's instructions. The quantity and purity of total RNA was determined by spectrophotometry readings at 260 and 280 nm. The integrity of intact total RNA was verified using a low RNA fluorescent linear amplification kit (Agilent). For hybridization, Cy3-labeled cRNA from siHIF-1␣ and siGFP-transfected cells, respectively, was combined and hybridized to Whole Mouse Genome Oligo Microarray 44K ϫ4 pack (Agilent), according to the manufacturer's protocol. Oligonucleotide microarray slides were scanned using an Agilent microarray scanner, and the gene expression profiles were analyzed using Agilent Whole Mouse Genome Oligo Microarray software. Western blot analysis. Cells were washed twice with PBS, harvested, and then lysed in UTB buffer (8 M urea, 50 mM Tris·HCL, pH 7.5, 150 mM 2-mercaptoethanol and deionized-water) or RIPA buffer (20 mM Tris·HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 1% Na deoxycholate, 0.1% SDS, deionized-water and protease inhibitors). After sonication and removal of debris by centrifugation, 50 g of protein from each sample were resolved by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were immunoblotted with the indicated antibodies and visualized with ECL (Amersham Biosciences, Piscataway, NJ). All experiments were repeated at least three times. The relative quantities of protein products were determined using ImageJ software for Windows.
ELISA. The concentration of PAI-1 protein in the BAL fluid and culture medium was measured using the mouse active PAI-1 ELISA kit (Innovative Research, Novi, MI) and PDGF-AA ELISA kit (R&D Systems, Minneapolis, MN), according to the manufacturer's instructions. Each sample was assayed in triplicate (n ϭ 5).
Statistical analysis. Data are expressed as means Ϯ SD. The differences were examined for significance using an ANOVA with Tukey's procedure post hoc comparison as appropriate, using SPSS software for Windows.
RESULTS

Expression of HIF-1␣ and PAI-1 in BLM-induced lung injury and fibrosis.
The early phase after BLM administration is characterized by acute inflammatory reaction: inflammatory cells such as neutrophils, macrophages, and lymphocytes infiltrate in the lung, and the increase of pro-inflammatory A: total RNA (left) was extracted from the left lung after instillation of BLM or saline. The expression of HIF-1␣, PAI-1, TGF-␤1 and procollagen was analyzed by RT-PCR. The mRNA levels of HIF-1␣, PAI-1, and TGF-␤1 (right) were normalized against the levels of 18S mRNA: the result are arbitrarily indicated as values relative to the levels in the controls and are the means Ϯ SD of three separate experiments. **Significant difference compared with controls (n ϭ 3; P Ͻ 0.01). B: bronchoalveolar lavage (BAL) was performed from control lung and BLM-instilled lung 1, 3, 7, and 14 days after BLM instillation. Activated-PAI-1 protein levels in BAL fluid (BALF) were measured by ELISA. Data represent means Ϯ SD from triplicate experiments (*P Ͻ 0.05; **P Ͻ 0.01). C: total RNA (left) was extracted from alveolar macrophages after instillation of BLM or saline. The expression of HIF-1␣ and PAI-1 was analyzed by RT-PCR. The mRNA levels of HIF-1␣ and PAI-1 (right) were normalized against the levels of 18S mRNA: the results are arbitrarily indicated as values relative to the levels in the controls and are means Ϯ SD of three separate experiments. **Significant difference compared with controls (P Ͻ 0.01; n ϭ 3).
cytokines (IL-1, TNF-␣) (32, 39) . The late phase is characterized by fibrotic reaction: the increase of pro-fibrotic markers (TGF-␤, PDGF), the proliferation and activation of fibroblasts, and extracellular matrix deposits (32) . To investigate whether HIF-1␣ was associated with pulmonary fibrosis through the production of PAI-1, we first examined the localization of HIF-1␣ and PAI-1 in the BLM-induced pulmonary inflammatory and fibrosis model by immunohistochemistry. As shown in Fig. 1, A and B, the expression of HIF-1␣ was increased on day 3 after BLM injection, which was not detected in control mice. Thereafter, the number of inflammatory cells was significantly increased, and most of the inflammatory cells were HIF-1␣ positive on day 7. The number of PAI-1 positive inflammatory cells was also significantly increased on day 7. The HIF-1␣ and PAI-1 positive cells were identified as alveolar macrophages because those cells were also mac3-positive (Fig. 1C) .
Next, we analyzed the change in expression of HIF-1␣, PAI-1, and TGF-␤ 1 mRNA by RT-PCR. As shown in Fig. 2A , the expression of PAI-1 and TGF-␤ 1 mRNA, but not HIF-1␣ mRNA, was barely detectable in control lungs and increased at 7 to 21 days after BLM instillation. The concentration of activated-PAI-1 protein was markedly increased in BAL fluid at 7 days after BLM instillation by ELISA (Fig. 2B) . On day 14, activated PAI-1 level was decreased and remained at the higher level on day 21. We also performed reverse zymography to examine the activity of PAI-1 but failed to show the change in PAI-1 activity. A failure might be due to the sensitivity problem of the zymogram to detect an increase in PAI-1 activity. These results indicate that PAI-1 protein expression as detected by immunohistochemistry was biologically active and suggests a role for PAI-1 in the fibrosing phase rather than the acute inflammatory phase in this model. Moreover, we obtained primary alveolar macrophages by BAL from C57BL/6 mice after BLM injection and examined the mRNA expression of HIF-1␣ and PAI-1. On day 7 and 14, PAI-1 mRNA expression, but not HIF-1␣, was increased in alveolar macrophages (Fig. 2C) .
Effect of TGF-␤ 1 on the expression of HIF-1␣ and PAI-1 in alveolar macrophage. It has been established that a key mediator implicated in BLM-induced pulmonary fibrosis is TGF-␤ 1 (4, 22) . Thus we next examined whether TGF-␤ 1 was directly were treated with TGF-␤1 (5 ng/ml) for up to 24 h (0, 2, 6, 12, 24 h). Then total RNA was extracted from macrophages. The expression of HIF-1␣ and PAI-1 mRNA was analyzed by real-time PCR. The mRNA levels of HIF-1␣ and PAI-1 were normalized against the levels of GAPDH mRNA: the results are arbitrarily indicated as values relative to the levels in the controls and are means Ϯ SD of three separate experiments. **Significant difference compared with controls (P Ͻ 0.01; n ϭ 3). C: serum-starved MH-S cells (left) were treated with TGF-␤1 (5 ng/ml) for up to 24 h (0, 2, 6, 12, 24 h). Then the whole cell lysates were subject to Western blot analysis to detect HIF-1␣ protein. The protein levels of HIF-1␣ (right) were normalized against the protein levels of ␤-actin: the results are arbitrarily indicated as values relative to the levels in the controls and are means Ϯ SD of three separate experiments. Significant difference compared with controls (n ϭ 3): *P Ͻ 0.05; **P Ͻ 0.01. D: activated-PAI-1 protein level in culture media were measured by ELISA. Data represent means Ϯ SD from triplicate experiments (*P Ͻ 0.05; **P Ͻ 0.01).
involved in the upregulation of HIF-1␣ and PAI-1 in MH-S cells, an established mouse alveolar macrophage cell line, and primary alveolar macrophages. Exposure of cells to TGF-␤1 (5 ng/ml) clearly increased PAI-1 but not HIF-1␣ mRNA levels shown by real-time PCR (Fig. 3A) . Moreover, in primary alveolar macrophages, TGF-␤ 1 stimulation also increased PAI-1 mRNA expression but not HIF-1␣ (Fig. 3B) . Western blot analysis showed that HIF-1␣ protein was induced by TGF-␤ 1 at 2 h after stimulation and reached a maximum at 6 h (Fig. 3C) , suggesting that TGF-␤ 1 increased HIF-1␣ protein expression predominantly at the posttranscriptional level. In addition, we found that the activated-PAI-1 protein concentration was robustly increased by TGF-␤ in culture medium of MH-S cells by ELISA (Fig. 3D) .
Inhibition of TGF-␤ 1 -induced HIF-1␣ protein expression by SB431542. To determine the intracellular signaling cascade mediating the induction of HIF-1␣ in response to TGF-␤ 1 , we examined the effects of protein kinase inhibitors on HIF-1␣ expression in MH-S cells. As shown in Fig. 4A , TGF-␤ 1 -induced HIF-1␣ expression was completely abrogated by SB431542 [type I TGF-␤ receptor/activin-like kinase 5 (ALK5) inhibitor], whereas neither PD98509 (MEK1 inhibitor) nor SB203580 (p38MAP kinase inhibitor) exerted measurable effects on TGF-␤ 1 induction of HIF-1␣ expression. Moreover, we examined whether SB431542 indeed inhibited ALK5-mediated Smad3-phosphorylation by using the antibody specific for phosphorylated Smad3. As shown in Fig. 4B , TGF-␤ 1 increased the phosphorylation of Smad3, and SB431542 efficiently blocked this effect. In a similar way, we examined the effects of TGF-␤ 1 on MEK1 and p38 MAPK phosphorylation. However, TGF-␤ 1 had no effects on phosphorylated forms of MEK1 (phospho p44/42) levels and phosphorylated form of p38 (phospho p38) levels (data not shown). These results were consistent with the data that neither PD98509 (MEK1 inhibitor) nor SB203580 (p38 inhibitor) blocked TGF-␤ 1 -induced HIF-1␣ expression.
HIF-1␣ is subjected to oxygen-dependent prolyl hydroxylation, and among the three prolyl-hydroxylase isoforms, PHD-1, PHD-2 and PHD-3, that hydroxylate the key proline residues A: serum-starved MH-S cells (left) were pretreated for 1 h with SB431542 (ALK5 receptor inhibitor), PD98059 (MEK1 inhibitor), and SB203580 (p38MAP kinase inhibitor), and then treated with TGF-␤1 (5 ng/ml) or vehicle for 6 h. Cells were harvested for analysis of HIF-1␣ protein by Western blot analysis. B and C: MH-S cells (left) were pretreated for 1 h with the indicated concentration of SB431542, and then treated by TGF-␤1 (5 ng/ml) or vehicle for 1 h. Cells were harvested for analysis of phosphorylated Smad3, total Smad3, HIF-1␣, PHD-1, PHD-2, PHD-3, and ␤-actin by Western blot analysis. A-C: the protein levels (right) of HIF-1␣, phosphorylated Smad3, total Smad3, and PHD-2 were normalized against the protein levels of ␤-actin. All experiments were repeated at least three times. The result are arbitrarily indicated as values relative to the levels in the controls and are means Ϯ SD of three separate experiments (*P Ͻ 0.05; **P Ͻ 0.01).
(Pro402 and Pro564) in vitro, PHD-2 plays the critical role in setting the low steady-state levels of HIF-1␣ in normoxia (2). In addition, McMahon et al. (31) showed that TGF-␤ 1 decreased PHD-2 mRNA and protein levels. Thus we examined whether PHD-2 was involved in TGF-␤ 1 -induced HIF-1␣ protein expression in alveolar macrophage. As shown in Fig.  4C , an induction of HIF-1␣ by TGF-␤ 1 was accompanied by a downregulation of PHD-2, and this response was abrogated by SB431542. These results suggest that TGF-␤ 1 -induced HIF-1␣ accumulation is mediated via ALK5-induced phosphorylation of Smad3 and a reduction of PHD-2 expression.
Inhibition of TGF-␤ 1 -induced PAI-1 protein expression by siRNA targeting HIF-1␣. To verify the role of HIF-1␣ in the TGF-␤ 1 -induced PAI-1 expression, we evaluated the impact of the specific silencing of HIF-1␣ on PAI-1 expression in MH-S cells. We transiently transfected MH-S cells with 21-bp siRNA duplexes corresponding to either HIF-1␣ or irrelevant GFP as a control, incubated the cells for 24 h, and then stimulated them with TGF-␤ 1 (5 ng/ml) for 6 h in normoxia. As shown in Fig. 5A , MH-S cells transfected with HIF-1␣ siRNA displayed a complete loss of HIF-1␣ protein, whereas transfection of siRNA targeting GFP did not abrogate HIF-1␣ expression. More importantly, HIF-1␣ siRNA but not GFP siRNA completely prevented the induction of HIF-1␣ protein by TGF-␤ 1 . Furthermore, real-time RT-PCR revealed that HIF-1␣ siRNA significantly blunted the TGF-␤ 1 induction of PAI-1 mRNA expression (P Ͻ 0.01) (Fig. 5B) . Consistently, MH-S cells transfected with HIF-1␣ siRNA showed a blunt increase in activated PAI-1 protein levels in the culture medium in response to TGF-␤ 1 (0.038 Ϯ 0.001 ng/ml vs. 0.018 Ϯ 0.003 ng/ml, siGFP vs. siHIF1␣; P Ͻ 0.05) (Fig. 5C) . These results demonstrated that TGF-␤ 1 induces PAI-1 expression largely through HIF-1␣-dependent mechanisms.
Expression profiling of the of TGF-␤ 1 -inducible genes through HIF-1␣ in MH-S cells.
To examine the role of HIF-1␣ in the TGF-␤ 1 induction of gene expression in alveolar macrophages, we performed a comprehensive gene expression pattern analysis using a microarray comprised of 45,019 probes. For these studies, MH-S cells were transiently transfected with siRNA targeting either HIF-1␣ or GFP, and incubated in normoxia in the presence or absence of TGF-␤ 1 (5 ng/ml) for 6 h. To simplify our analyses, we compared the fold-difference of TGF-␤ 1 induction of each mRNA expression in MH-S cells. Table 2 lists the genes whose expression was induced by TGF-␤ 1 less preferentially in MH-S cells transfected with HIF-1␣ siRNA than in cells transfected with GFP siRNA. This analysis identified 58 genes that were upregulated more than twofold by TGF-␤ and abrogated by HIF-1␣ silencing. These genes included PAI-1, growth factors, and receptors such as PDGF-A and type I TGF-␤ receptor, transcription factors, and cofactors such as HIF-1␣, Snail, Id1, Id2, and Id3, anti-peptidase such as Serpine, and multiple genes implicated in carbohydrate and lipid metabolism. Notably, HIF-1␣ mRNA levels were increased 2.71-fold by TGF-␤ 1 , and HIF-1␣ silencing markedly inhibited this induction, suggesting the auto-regulation of HIF-1␣ gene expression in response to TGF-␤ 1 . To validate the microarray analysis, we examined the effects of TGF-␤ 1 and HIF-1␣ siRNA silencing on PDGF-A expression. As shown in Fig. 5D , real-time RT-PCR showed that TGF-␤ 1 increased PDGF-A mRNA levels ϳ4.2-fold in MH-S cells transfected with the GFP siRNA, and this induction was significantly blunted in MH-S cells transfected with HIF-1␣ siRNA. These results were confirmed by ELISA, indicating that PDGF-A is upregulated by TGF-␤ 1 by, at least in part, HIF-1␣-dependent mechanisms (Fig. 5E) .
Effect of PHD-2 silensing on HIF-1␣ protein expression. To investigate the involvement of PHD-2 in the HIF-1␣ induction by TGF-␤ 1 stimulation, we transfected MH-S cells with PHD-2 siRNA or GFP siRNA, incubated the cells for 24 h, and then stimulated them with TGF-␤ (5 ng/ml) for 6 h in normoxia. As shown in Fig. 6 , PHD-2 protein expression was substantially reduced in PHD-2 siRNA transfected cells compared with GFP siRNA transfected cells. We found that PHD-2 siRNA but not GFP siRNA clearly increased HIF-1␣ protein levels. In addition, an increase in HIF-1␣ protein levels by TGF-␤ 1 was clearly enhanced in MH-S cells transfected with PHD-2 siRNA. These results suggest that TGF-␤ 1 induction of PHD-2 expression is causally linked with a downregulation of PHD-2 expression by TGF-␤ 1 .
Effect of hypoxia on the expression of HIF-1␣ and PAI-1 in alveolar macrophage. We examined the effects of hypoxia on HIF-1␣ and PAI-1 expression in MH-S cells. Western blot analysis showed that a low oxygen concentration (8%) modestly increased HIF-1␣ expression but had no measurable effects on PAI-1 production (Fig. 7, A and B) . In contrast, an oxygen concentration of Ͻ1% clearly increased steady-state levels of HIF-1␣ protein and activated PAI-1 production (Fig.  7, C and D) . It is interesting to note that the magnitude of the increase in HIF-1␣ protein levels induced by TGF-␤ 1 was less than that induced by Ͻ1% oxygen, despite the increased production of PAI-1 induced by TGF-␤ compared with Ͻ1% oxygen. These results suggest that, although an increase in PAI-1 production by either TGF-␤ 1 or hypoxia is mediated by HIF-1␣ accumulation, the mechanisms by which TGF-␤ 1 and hypoxia increase PAI-1 production are different from each other.
We next examined the cooperative effects of hypoxia and TGF-␤ 1 on HIF-1␣ and PAI-1 expression. Compared with TGF-␤ 1 stimulation in normoxia, TGF-␤ 1 and Ͻ1% oxygen remarkably induced HIF-1␣ and PAI-1 production, although 8% oxygen had less additive effect on HIF-1␣ and PAI-1 production (Fig. 7, E and F) . These results suggest that there is cross-talk between the signal transduction pathways induced by TGF-␤ 1 and Ͻ1% hypoxia resulting in stimulation of TGF-␤ 1 gene transcription.
DISCUSSION
Here, we demonstrate that HIF-1␣ is abundantly expressed in alveolar macrophages in a mouse BLM-induced pulmonary fibrosis model at the alveolitis stage (day 7) and in interstitial cells at the fibro-proliferating stage (day 14). Among numerous genes that are known to be regulated by HIF-1␣, we focus on the PAI-1 gene because PAI-1 has been documented as a pro-fibrotic mediator of lung fibrosis both in animal models and in humans (3, 46) . Our immunohistochemistry data showed predominant expression of PAI-1 and HIF-1␣ in alveolar macrophages in the mouse BLM-induced pulmonary fibrosis model, and an in vitro study using MH-S cells demonstrated that TGF-␤ 1 induced HIF-1␣ stabilization via ALK5/ Smad3 signaling and PHD2 downregulation in normoxia. Notably, HIF-1␣ silencing attenuated TGF-␤ 1 induction of PAI-1 expression, indicating the crucial role of HIF-1␣ in mediating TGF-␤ 1 induction of PAI-1 expression.
One of the major findings in this study is that alveolar macrophages respond to TGF-␤ 1 to induce PAI-1. This finding Fig. 6 . Effect of PHD-2 siRNA on TGF-␤1 induced HIF-1␣ expression. Left: serum-starved MH-S cells were transfected with PHD-2 siRNA or GFP siRNA (control) for 24 h and then treated with TGF-␤1 (5 ng/ml) or vehicle for 6 h. Whole cell extracts were analyzed for PHD-2 and HIF-1␣ protein expression by Western blot analysis. ␤-Actin was measured as internal control. Right: the protein levels of PHD-2 and HIF-1␣ were normalized against the protein levels of ␤-actin. All experiments were repeated at least three times. Data represent means Ϯ SD from triplicate experiments (*P Ͻ 0.05; **P Ͻ 0.01).
expands our concept of the role of activated alveolar macrophages in fibrosis to be more than just the cells that produce a variety of cytokines, oxidants, and profibrosing products, including TGF-␤ 1 . Few studies have described that alveolar macrophages respond to TGF-␤ 1 despite the major advances being made in understanding its role in pulmonary fibrosis. Most of the previous studies showed that TGF-␤ exerts its effects on alveolar epithelial cells or resident fibroblasts to induce the production of organized alveolar exudates with proliferating myofibroblasts and synthesis of connective tissue (11, 21, 35, 51, 53) . Our study showed for the first time that TGF-␤ 1 induces PAI-1 and PDGF-A production in alveolar macrophages through ALK5 activation and Smad3 phosphorylation.
In this study, we demonstrated that HIF-1␣ expression was increased in alveolar macrophages in the BLM model of pulmonary fibrosis. These results are consistent with a previous study using microarray-based mRNA profiling of IPF patients, which demonstrates an increase in the expression of the genes that regulate oxygen transport and the hypoxic response (49). Higgins et al. (16) showed that, in cultured tubular epithelial cells and in a murine unilateral ureteral obstruction (UUO) model of tubulointerstitial fibrosis, hypoxic stabilization of HIF-1␣ in renal epithelial cells promotes interstitial fibrosis via the induction of EMT. In addition, Madjdpour et al. (28) described that alveolar hypoxia induced macrophage recruitment and enhanced expression of HIF-1␣ and inflammatory mediators. Thus it is possible that hypoxia in alveolar macrophages in BLM-induced pulmonary fibrosis is attributable to the accumulation of HIF-1␣ in those cells. However, this assumption is unlikely because the alveolar space does not seem to be hypoxic enough to induce HIF-1␣, given that HIF-1␣ stabilization can occur at oxygen tensions lower than 5% O 2 (equivalent to ϳ38 Torr) (16) . Therefore, we hypothesize that HIF-1␣ accumulates in alveolar macrophages in normoxia during pulmonary fibrosis at the alveolitis stage in vivo.
Other than hypoxic activation, HIF-1␣ has been reported to be activated by growth factors, cytokines, hormones, or nitric oxide (NO) (9, 10, 12, 15, 18, 38, 45) . Signal transduction pathway investigations demonstrated that HIF-1␣ protein levels are subjected to complex modulation by those stimuli in normoxia. In tubular cells, HIF-1␣ stabilization by NO and inflammatory cytokines are reactive oxygen species (ROS)-sensitive (37, 38) , whereas in HepG2 cells this process is mediated by phosphatidyl inositol 3-kinase (PI3K)-AKT signaling (45) . With regard to insulin and insulin-like growth factor-1 (IGF-1), and possibly other tyrosine kinase such as EGF receptor and v-Src, an increase in HIF-1␣ protein levels is due to an increase in the rate of HIF-1␣ protein synthesis. This increase is mediated by the PI3K-AKT-FRAP (FKBPrapamycin-associated protein) pathway that phosphorylates and activates the translational regulatory proteins eIF-4E-binding protein 1 and p70 S6 kinase (p70 S6K ) (23, 24) . In addition, mitogen-activated protein kinase (MAPK) is required for HIF-1␣ induction by IGF-1 (9) . In this study, we showed that TGF-␤ 1 increases HIF-1␣ protein levels through a decrease in the expression of a key limiting prolyl-4-hydroxylases, PHD-2, that hydoxylates HIF-1␣ at two proline residues (Pro402 and Pro564).
Our finding that TGF-␤ 1 induces PAI-1 expression in a HIF-1␣-dependent manner merits further discussion. It is noteworthy that magnitude of induction by TGF-␤ 1 is more predominant than that induced by Ͻ1% hypoxia, despite the fact that the accumulation of HIF-1␣ following TGF-␤ 1 stimulation is less than that observed in 1% hypoxia. The most plausible explanation for this discordance between HIF-1␣ and PAI-1 induction by TGF-␤ may be explained as depicted in Fig. 8 . TGF-␤ 1 induces PAI-1 gene expression through at least two distinct mechanisms. In addition to the mechanism identified in this study, a previous study demonstrated that PAI-1 gene expression is highly induced by TGF-␤ 1 through the TGF-␤-responsive element, referred to as the CAGA box, to which Smad3/Smad4 bind (7). In contrast, hypoxic induction of PAI-1 gene expression is exclusively dependent on the HIF-1/ hypoxia response element (HRE) (20) . Thus we assume that TGF-␤ 1 induction of PAI-1 gene expression is mediated by both CAGA box and HRE, whereas hypoxic induction is mostly or completely mediated by HRE alone.
Stimulation of MH-S cells with TGF-␤ 1 under hypoxia (Ͻ1% O 2 ) robustly increased PAI-1 protein levels, suggesting that the effects of TGF-␤ 1 and hypoxia on PAI-1 expression are synergistic rather than additive. Although the precise mechanisms underlying these results remain unclear, it is intriguing to speculate that the HIF-1/HRE complex and Smad3/4/ CAGA-box complex directly or indirectly interact and activate PAI-1 gene transcription. Further study using the PAI-1 promoter mutation constructs containing either the CAGA box or HRE are required to prove this hypothesis.
To date, over 100 genes are known to be targets of HIF-1␣ under low oxygen concentrations (typically Ͻ2% O 2 ). Those include the genes involved in glucose metabolism, erythropoiesis, angiogenesis, vascular tone, cell proliferation, and apoptosis (41) . Our microarray analyses of TGF-␤ 1 stimulation of MH-S cells with or without HIF-1␣ silencing revealed that TGF-1 regulates a cluster of genes relevant to fibrosis through a HIF-1-dependent mechanism. These include PAI-1, PDGF-A, and type I TGF-␤ receptor. Previous studies with HIF-1␣ knockout mice revealed that HIF-1 activity is required not only for the O 2 homeostasis under reduced oxygen conditions but also for the immune system under normoxic condition (6) . Our study provides clues to understanding macrophage biology in the regulation of the inflammation and fibrosis in response to the inflammatory microenvironment in which a variety of cytokines, including TGF-␤ 1 , are locally expressed and input signals into macrophages. Our study also supports the hypothesis that HIF-1␣ plays an early role in the development of pulmonary fibrosis, which has been proposed by Tzouvelekis et al. (49) . They performed comparative expression profiling and meta-analysis of the results from different animal models and IPF patients and found that HIF-1␣ signaling was a statistically significant deregulated pathway.
In conclusion, our study provides convincing data indicating the effects of TGF-␤ 1 on PAI-1 expression in alveolar macrophages mediated via ALK5/Smad3. In addition, this study has highlighted a crucial role of HIF-1␣ in mediating the effects of TGF-␤ 1 on PAI-1 expression. We showed that TGF-␤ 1 induces PAI-1 and PDGF-A expression via HIF-1␣-dependent mech- Binding of TGF-␤1 to the type II receptor (TGF-␤RII) allows this receptor to bind to the type I receptor (TGF-␤RI) on the cell surface of the alveolar macrophage, resulting in phosphorylation of the kinase domain of the type I receptor. This in turn phosphorylates the transcription factors Smad2 or Smad3, which bind to Smad4, the common Smad, and the resulting complex moves from the cytoplasm into the nucleus. In the nucleus, the Smad complex binds to the CAGA box, which serves as Smad binding element (SBE) within the PAI-1 promoter and induces transcription. Our study showed that TGF-␤1 decreases PHD2 expression via the ALK5/Smad3 pathway. Under conditions where PHD2 expression is decreased, HIF-1␣ translocates to the nucleus, forms a complex with the p300/CBP coactivator proteins, and heretodimeraizes with HIF-1␤. The HIF-1␣/HIF-1␤ dimer recognizes the HRE to induce PAI-1 gene translocation. Under conditions where PHD2 expression remains high, such as in normoxia or no TGF-␤1 stimulation, HIF-1␣ is hydroxylated on conserved prolyl residues and subjected to polyubiquitination by the pVHL complex and proteasomal degradation.
anisms in normoxia, and the effects of TGF-␤ 1 on hypoxic cells were remarkable. Combined with the microarray data that identify a set of genes regulated by TGF-␤ 1 via HIF-1␣ in MH-S cells, these data have relevance to the pathogenesis of pulmonary fibrosis given that a number of HIF-1-dependent genes are expressed in IPF patients. The role of HIF-1␣ in macrophages in pulmonary fibrosis in vivo needs to be verified by experiments using alveolar macrophage-specific HIF-1␣ knockout mice.
